Key result
Dobutamine stress echocardiography is a safe and reliable method for diagnosing coronary artery disease and stratifying cardiovascular risk in patients with diabetes.
Why the study?
Does dobutamine stress echocardiography provide accurate diagnosis and prognostic information for coronary artery disease in patients with diabetes?
Does dobutamine stress echocardiography provide accurate diagnosis and prognostic information for coronary artery disease in patients with diabetes?
Dobutamine stress echocardiography is a safe and reliable method for diagnosing coronary artery disease and providing prognostic information in patients with diabetes.
Answers are grounded in this paper and cite their sources.
May support dobutamine stress echocardiography for CAD evaluation in diabetes; leaves open need for randomized validation.
Cardiovascular disease is the leading cause of death in patients with diabetes so prompt diagnosis and treatment of high-risk groups is essential. Dobutamine stress echocardiography is a safe, cheap and reliable method for coronary artery disease diagnosis and provides important long-term prognostic information. The diagnostic accuracy and prognostic predictive power of this technique have been validated by a number of studies on patients with and without diabetes. This article discusses the place of dobutamine stress echocardiography in current cardiology practice and, in particular, its role in the cardiovascular risk stratification of patients with diabetes.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2005) conducted a review in Diabetes and cardiovascular disease. Dobutamine stress echocardiography was evaluated. Dobutamine stress echocardiography is a safe and reliable method for diagnosing coronary artery disease and stratifying cardiovascular risk in patients with diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: